Clinical trials: a step towards ironing out regulatory ambiguities | Amarchand Mangaldas
In 2005, India was the ‘go to’ destination for conducting clinical trials. However, recent articles indicate that, since then, the growth trajectory of the clinical trials industry in India has suffered due to the lack of clarity in the regulatory framework governing these trials. In order to resolve the ambiguity under the current regime and …
Continue reading “Clinical trials: a step towards ironing out regulatory ambiguities ”

